# International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial

Study · id `cardio:ct-nct06566183` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06566183](<https://clinicaltrials.gov/study/NCT06566183>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06566183

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT06566183. Randomized; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2030-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT06566183, source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06566183, source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)
- Primary completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT06566183, source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)
- Completion: 2032-12 (anticipated) (ClinicalTrials.gov record NCT06566183, source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)
- Countries: United States; Brazil; India; Mexico; Poland; South Korea (ClinicalTrials.gov record NCT06566183, source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06566183-2026-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial
- Acronym: ISCHEMIA-LVD
- Condition: Coronary Artery Disease
- Condition: Cognitive Impairment
- Condition: Heart Failure
- Intervention (Procedure): Guideline-directed medical therapy (GDMT)
- Intervention (Procedure): Coronary artery bypass grafting (CABG)
- Intervention (Procedure): Percutaneous coronary intervention (PCI).
- Lead sponsor: NYU Langone Health
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: NYU Langone Health (`cardio:org-nyu-langone-health`)

## Provenance

Content hash: e8bf342d5f87a3692f5145dad8f802805952b059d04da342f2faf7dcc854a649
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
